Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bleselumab (ASKP 1240), a human anti-CD40 monoclonal antibody (mAb), exhibits high-affinity binding to CD40 (Kd: 0.24 nM) and hinders immune responses by impeding the CD40-CD40L interaction, thereby preventing organ transplant rejection [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Bleselumab (ASKP 1240), a human anti-CD40 monoclonal antibody (mAb), exhibits high-affinity binding to CD40 (Kd: 0.24 nM) and hinders immune responses by impeding the CD40-CD40L interaction, thereby preventing organ transplant rejection [1]. |
In vitro | Bleselumab, at a concentration of 0-1 μg/mL attenuates the proliferation of peripheral blood mononuclear cells (PBMCs) over 48 hours in a dose-dependent manner when induced by soluble CD154 [2]. |
In vivo | Bleselumab administered intravenously at dosages ranging from 0.1 to 10 mg/kg suppresses delayed-type hypersensitivity (DTH) reactions in cynomolgus monkeys [2]. At 2 mg/kg, it extends the lifespan of renal allografts in these subjects [3]. Additionally, when combined with Tacrolimus, bleselumab at either 2 or 5 mg/kg demonstrates an increased median survival time (MST) compared to when used alone [3]. |
Synonyms | ASKP 1240, Anti-Human CD40 Recombinant Antibody |
Molecular Weight | N/A |
CAS No. | 1453067-91-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bleselumab 1453067-91-8 ASKP 1240 Anti-Human CD40 Recombinant Antibody inhibitor inhibit